×

Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes

DC
  • US 5,767,097 A
  • Filed: 01/23/1996
  • Issued: 06/16/1998
  • Est. Priority Date: 01/23/1996
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of modulating Th1 and Th2 response in activated T cells of a human patient comprising administering Ribavirin to the T cells in a dosage which promotes the Th1 response and suppresses the Th2 response.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×